data_1za8_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1za8 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.621 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 HG21 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' HD11 ' A' ' 30' ' ' ILE . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.684 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.684 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.64 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.7 p30 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.658 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.615 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 19.1 p30 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' HD2' ' A' ' 23' ' ' LYS . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.569 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.724 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.496 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.442 ' HE1' HG23 ' A' ' 8' ' ' ILE . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.442 HG23 ' HE1' ' A' ' 7' ' ' MET . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.921 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 18' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.921 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 16' ' ' ILE . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 13' ' ' THR . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.585 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.724 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.715 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.715 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 18' ' ' CYS . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.604 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG21 ' HD2' ' A' ' 23' ' ' LYS . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.719 ' SG ' HD21 ' A' ' 27' ' ' LEU . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.72 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.72 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.481 HG23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.673 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.673 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.719 HD21 ' SG ' ' A' ' 1' ' ' CYS . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.478 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.561 ' OE1' HG21 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.547 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.561 HG21 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.514 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.452 ' HB3' HG22 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.632 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.632 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.584 HG21 ' OE1' ' A' ' 3' ' ' GLU . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 24' ' ' VAL . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.62 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 21' ' ' LYS . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' HG21 ' A' ' 24' ' ' VAL . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.626 ' OE1' HG21 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.753 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.626 HG21 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.2 p30 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.569 ' SG ' HD23 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' SG ' ' A' ' 18' ' ' CYS . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.55 ' SG ' HG22 ' A' ' 13' ' ' THR . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.607 HD22 ' HB ' ' A' ' 30' ' ' ILE . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.607 ' HB ' HD22 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB3' HG23 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.474 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.8 p30 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.577 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.606 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.876 ' HE3' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 27' ' ' LEU . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.616 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.616 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 ' SG ' ' A' ' 18' ' ' CYS . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 13' ' ' THR . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.47 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.572 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.616 ' HD2' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 23' ' ' LYS . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.45 ' HA ' HD11 ' A' ' 16' ' ' ILE . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.662 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 20.3 p30 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 21' ' ' LYS . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.639 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.747 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.509 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 16' ' ' ILE . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.572 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.673 ' SG ' HD22 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.873 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.873 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.944 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.944 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.609 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.673 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.486 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.661 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.821 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.52 ' O ' HG21 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.819 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.561 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ILE . . . . . 0.404 HG23 HG12 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.5 p30 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.621 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.443 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.461 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.443 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.645 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 HG21 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.645 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.572 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.568 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.449 ' HA ' HD11 ' A' ' 30' ' ' ILE . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.51 ' HB3' HG23 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.684 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.658 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.691 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.684 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.691 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.403 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.64 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.7 p30 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.658 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.63 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.63 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.484 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.619 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.551 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.615 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.443 ' CG1' HD11 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.615 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.481 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.57 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.619 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.541 ' SG ' HD22 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.586 ' OE1' HG23 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.599 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.586 HG23 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.599 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 19.1 p30 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.714 ' HD2' HG22 ' A' ' 24' ' ' VAL . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.714 HG22 ' HD2' ' A' ' 23' ' ' LYS . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.532 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.593 ' HB3' ' SG ' ' A' ' 18' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.569 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.646 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.724 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.426 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.496 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.442 ' HE1' HG23 ' A' ' 8' ' ' ILE . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.442 HG23 ' HE1' ' A' ' 7' ' ' MET . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.426 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.921 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.422 HG23 ' SG ' ' A' ' 18' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.921 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 16' ' ' ILE . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.422 ' SG ' HG23 ' A' ' 13' ' ' THR . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.503 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.585 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.585 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.507 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.724 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.507 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.646 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.613 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.715 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.527 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.527 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.715 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.557 HG21 ' SG ' ' A' ' 18' ' ' CYS . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.694 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.694 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.529 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.604 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG21 ' HD2' ' A' ' 23' ' ' LYS . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.613 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.719 ' SG ' HD21 ' A' ' 27' ' ' LEU . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.72 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.55 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . 0.439 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.72 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.481 HG23 ' SG ' ' A' ' 18' ' ' CYS . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.604 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.583 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.673 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.673 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.579 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.719 HD21 ' SG ' ' A' ' 1' ' ' CYS . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.478 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.561 ' OE1' HG21 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.475 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.547 ' HB2' ' HE3' ' A' ' 23' ' ' LYS . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.475 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.597 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.561 HG21 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.597 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.514 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.406 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.622 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.622 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.438 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.608 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.438 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.595 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.595 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.456 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.669 ' HZ2' ' HB3' ' A' ' 23' ' ' LYS . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.524 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.524 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.452 ' HB3' HG22 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.632 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.48 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.487 ' N ' HD12 ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.632 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.584 HG21 ' OE1' ' A' ' 3' ' ' GLU . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.614 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.486 ' O ' HG12 ' A' ' 24' ' ' VAL . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.62 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.62 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 21' ' ' LYS . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.463 ' CE1' HG21 ' A' ' 24' ' ' VAL . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.654 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.626 ' OE1' HG21 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.589 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.753 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.626 HG21 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.613 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.602 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.2 p30 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.589 ' HG3' ' HB1' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.508 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.508 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.654 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.569 ' SG ' HD23 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.405 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.562 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.55 HG22 ' SG ' ' A' ' 18' ' ' CYS . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.562 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.55 ' SG ' HG22 ' A' ' 13' ' ' THR . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.604 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.604 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.607 HD22 ' HB ' ' A' ' 30' ' ' ILE . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.607 ' HB ' HD22 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.446 ' HB3' HG23 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.478 HD12 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.683 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.474 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.683 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.445 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.86 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.515 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.8 p30 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.577 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.577 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.445 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.451 HD11 HG21 ' A' ' 30' ' ' ILE . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.606 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.876 ' HE3' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.606 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.449 HG22 ' SG ' ' A' ' 18' ' ' CYS . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.57 ' HG3' ' O ' ' A' ' 18' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.509 ' HZ2' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.53 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.588 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.457 HD22 ' HA ' ' A' ' 27' ' ' LEU . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.591 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.616 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.434 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.616 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.549 HG23 ' SG ' ' A' ' 18' ' ' CYS . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.6 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.549 ' SG ' HG23 ' A' ' 13' ' ' THR . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.47 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.572 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.572 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.616 ' HD2' HG23 ' A' ' 24' ' ' VAL . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' A' ' 23' ' ' LYS . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.591 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.639 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.545 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.507 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.63 ' HB3' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.492 ' SD ' HG21 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG21 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.507 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.633 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.633 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.45 ' HA ' HD11 ' A' ' 16' ' ' ILE . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.626 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.451 ' O ' HG23 ' A' ' 24' ' ' VAL . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.662 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 20.3 p30 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.662 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 21' ' ' LYS . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.639 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.747 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.442 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.509 ' HB1' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.747 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.407 ' HA ' HD13 ' A' ' 16' ' ' ILE . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.569 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.456 HG22 HD12 ' A' ' 16' ' ' ILE . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.572 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.572 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.673 ' SG ' HD22 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.873 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.873 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.944 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.944 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.608 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.609 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.673 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.486 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.661 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.582 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.821 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.644 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.52 ' O ' HG21 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.644 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.52 HG21 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.564 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.606 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.819 ' HZ1' ' HB2' ' A' ' 23' ' ' LYS . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . 0.661 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . 0.54 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.669 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.624 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.537 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.561 ' HE1' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.624 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.707 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG12 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ILE . . . . . 0.404 HG23 HG12 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.707 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASN . . . . . 0.566 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.5 p30 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.566 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.669 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 13' ' ' THR . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.656 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.656 HG22 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 13' ' ' THR . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.698 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 13' ' ' THR . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.605 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.538 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.617 HD23 ' SG ' ' A' ' 1' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.571 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.741 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.91 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 1' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.91 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 13' ' ' THR . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.719 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 13' ' ' THR . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.732 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.682 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 13' ' ' THR . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.647 ' OE1' HG22 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.647 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.63 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.706 ' HB3' HG21 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.669 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.706 HG21 ' HB3' ' A' ' 1' ' ' CYS . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.624 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.672 ' OE1' HG22 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.672 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.503 ' OE1' HG22 ' A' ' 13' ' ' THR . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.503 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.482 ' HB3' HG21 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.491 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 13' ' ' THR . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.495 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 13' ' ' THR . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.595 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.655 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.655 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.479 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.644 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 13' ' ' THR . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 21' ' ' LYS . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.6 OUTLIER 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' ND2' ' A' ' 22' ' ' ASN . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.754 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.903 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PHE . . . . . 0.404 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.903 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.954 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.626 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD23 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.679 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.447 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.621 ' O ' HG22 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.679 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.64 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 3' ' ' GLU . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.728 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.68 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 13' ' ' THR . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.656 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.656 HG22 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 13' ' ' THR . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.698 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 13' ' ' THR . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.605 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.617 HD23 ' SG ' ' A' ' 1' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.571 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.741 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.91 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 1' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.91 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 13' ' ' THR . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.719 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 13' ' ' THR . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.732 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.682 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 27' ' ' LEU . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.2 t-20 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 13' ' ' THR . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.647 ' OE1' HG22 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.647 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.63 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.706 ' HB3' HG21 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.669 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.706 HG21 ' HB3' ' A' ' 1' ' ' CYS . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.624 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.672 ' OE1' HG22 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.672 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.503 ' OE1' HG22 ' A' ' 13' ' ' THR . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.503 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.482 ' HB3' HG21 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.491 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.88 ' HE3' ' HA ' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 13' ' ' THR . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.495 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 13' ' ' THR . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.595 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.655 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.655 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 37.3 t-20 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.479 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.644 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 13' ' ' THR . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 21' ' ' LYS . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.6 OUTLIER 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.437 HG22 ' ND2' ' A' ' 22' ' ' ASN . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 36.8 t-20 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.754 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.5 OUTLIER 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.903 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PHE . . . . . 0.404 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.903 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.954 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.626 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD23 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.679 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.447 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.621 ' O ' HG22 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.679 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.64 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 3' ' ' GLU . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.728 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.4 OUTLIER 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.68 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 13' ' ' THR . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.656 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.656 HG22 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 13' ' ' THR . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.698 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.7 p30 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 13' ' ' THR . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.605 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.674 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 19.1 p30 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.538 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.617 HD23 ' SG ' ' A' ' 1' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.571 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.741 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.91 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 1' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.91 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 13' ' ' THR . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.719 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 13' ' ' THR . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.732 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.682 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 13' ' ' THR . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.647 ' OE1' HG22 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.647 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.63 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.706 ' HB3' HG21 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.669 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.65 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.706 HG21 ' HB3' ' A' ' 1' ' ' CYS . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.624 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.672 ' OE1' HG22 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.672 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.2 p30 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.503 ' OE1' HG22 ' A' ' 13' ' ' THR . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.503 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.482 ' HB3' HG21 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.491 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.8 p30 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 13' ' ' THR . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.495 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 13' ' ' THR . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.595 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.655 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.655 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.582 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.479 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.644 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 13' ' ' THR . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 21' ' ' LYS . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 20.3 p30 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.754 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.903 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . 0.404 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.903 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.954 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.626 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.662 HD23 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.49 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.679 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.447 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.621 ' O ' HG22 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.679 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.64 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 3' ' ' GLU . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.728 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.5 p30 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.68 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.607 ' HB3' HG21 ' A' ' 13' ' ' THR . 71.3 m . . . . . 0 CA--C 1.522 -0.097 0 CA-C-O 120.883 0.373 . . . . 0.0 110.768 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.4 38.76 96.89 Favored Glycine 0 C--O 1.228 -0.272 0 CA-C-N 115.898 -0.592 . . . . 0.0 112.818 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.656 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.8 tt0 -150.39 154.81 38.42 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 42.9 p -134.38 133.31 40.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.068 0.461 . . . . 0.0 111.673 -179.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.456 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -94.59 37.34 1.13 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.73 178.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.432 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -61.08 -36.68 80.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 114.949 -1.023 . . . . 0.0 112.332 -179.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 52.1 ttp -88.56 -60.17 2.03 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.657 0.742 . . . . 0.0 110.458 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -117.61 137.59 51.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.533 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.456 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.3 t -75.79 48.6 0.48 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.218 0.532 . . . . 0.0 111.151 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -151.42 117.1 5.43 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.117 178.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.665 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 34.5 m -95.43 148.95 21.92 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.64 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -69.21 -38.5 78.61 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.656 HG22 ' OE1' ' A' ' 3' ' ' GLU . 14.4 t -78.61 -3.6 44.67 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.18 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.665 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 7.4 tt0 -66.91 -38.98 87.24 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.547 0.689 . . . . 0.0 109.982 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 24.1 t -58.51 -32.92 46.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 114.926 -1.034 . . . . 0.0 112.425 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.405 HG12 ' O ' ' A' ' 13' ' ' THR . 34.4 pt -86.44 -11.37 11.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -178.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 153.02 -31.72 0.8 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 119.343 -1.408 . . . . 0.0 114.026 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.581 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 89.1 m -63.32 169.91 3.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.053 0.426 . . . . 0.0 111.692 -179.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.421 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 12.7 p -147.33 139.69 24.61 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.721 -179.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 30.0 t -70.62 130.86 42.9 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.235 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.487 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 82.8 tttt -149.93 123.43 9.08 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.0 p-10 43.91 47.29 6.99 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.325 0.65 . . . . 0.0 112.503 -179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 31.6 ttpt 78.12 -12.97 1.01 Allowed 'General case' 0 N--CA 1.473 0.724 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.8 p -113.89 138.6 43.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 O-C-N 121.173 -0.955 . . . . 0.0 111.678 179.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 12.8 m -83.48 115.55 22.13 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.582 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.15 156.54 41.62 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.494 0.664 . . . . 0.0 111.924 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 40.8 tp -135.19 104.26 5.84 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.75 -1.113 . . . . 0.0 108.531 178.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.7 t30 57.89 44.87 19.25 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.52 0.676 . . . . 0.0 109.543 -178.639 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 44.0 m 70.5 6.28 5.74 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-N 114.871 -1.059 . . . . 0.0 112.173 -179.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.4 mm -94.7 132.98 37.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.9 m . . . . . 0 C--N 1.326 -0.456 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.532 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 13' ' ' THR . 92.3 m . . . . . 0 CA--C 1.522 -0.114 0 CA-C-O 120.761 0.315 . . . . 0.0 110.811 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.5 38.48 96.39 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.39 179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.698 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.3 tt0 -149.56 149.84 31.34 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 34.9 p -131.07 131.1 44.01 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.057 0.456 . . . . 0.0 111.838 -178.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.1 p -92.44 34.11 1.07 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.744 178.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.602 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -67.4 -30.7 70.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.21 -0.904 . . . . 0.0 111.768 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 47.4 ttp -88.24 -53.47 4.68 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.613 0.721 . . . . 0.0 110.027 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.3 pt -131.43 141.25 46.34 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.76 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.3 t -76.33 52.06 0.74 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.326 0.584 . . . . 0.0 110.822 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -151.02 117.6 5.74 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.19 -0.914 . . . . 0.0 109.226 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.695 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 57.2 m -96.02 142.14 28.59 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 116.044 -0.525 . . . . 0.0 109.84 179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -70.11 -30.47 67.68 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 178.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.3 t -92.93 1.89 57.07 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 -179.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.695 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 13.0 pt-20 -71.37 -33.77 69.85 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 119.458 -0.897 . . . . 0.0 110.757 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.3 m -63.31 -23.63 33.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.092 0.472 . . . . 0.0 110.492 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.3 mm -79.74 -31.72 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.691 -0.686 . . . . 0.0 110.645 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 161.89 -28.63 0.28 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.524 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.496 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 73.8 m -62.45 169.32 3.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.136 0.493 . . . . 0.0 111.731 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 27.8 m -150.08 137.49 19.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.141 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 24.0 t -67.82 129.92 41.38 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.45 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HE2' ' CD2' ' A' ' 26' ' ' TYR . 39.9 ttpt -146.42 119.99 9.13 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.638 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.7 p30 46.28 47.46 13.53 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.629 0.772 . . . . 0.0 112.658 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.638 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.1 ttpp 81.77 -15.2 0.73 Allowed 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.387 0.884 . . . . 0.0 113.387 178.453 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.639 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.7 t -114.54 137.74 46.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 O-C-N 121.372 -0.83 . . . . 0.0 111.223 179.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 34.2 m -81.46 122.57 27.68 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.255 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.639 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.2 m-85 -127.94 146.03 50.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.229 0.538 . . . . 0.0 112.206 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 37.7 tp -114.7 100.25 8.12 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 177.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 50.8 t30 61.22 40.98 13.97 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 -177.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 72.5 m 73.68 2.53 4.27 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 114.261 -1.336 . . . . 0.0 112.705 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.7 mm -88.73 134.82 27.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 178.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.325 -0.463 0 CA-C-O 120.985 0.421 . . . . 0.0 111.377 -179.244 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.633 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.0 m . . . . . 0 CA--C 1.521 -0.147 0 CA-C-O 120.971 0.415 . . . . 0.0 110.586 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.25 37.22 94.22 Favored Glycine 0 C--O 1.227 -0.319 0 CA-C-N 115.755 -0.657 . . . . 0.0 112.547 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.552 ' OE1' HG22 ' A' ' 13' ' ' THR . 11.6 tt0 -145.1 160.83 40.8 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.448 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.5 p -140.94 131.29 25.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.132 0.491 . . . . 0.0 111.766 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.5 p -92.78 39.59 1.04 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.989 0.899 . . . . 0.0 108.75 178.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.521 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.23 -34.82 74.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 114.348 -1.297 . . . . 0.0 112.852 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.5 tpt -88.68 -56.52 3.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.695 0.76 . . . . 0.0 110.588 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.3 pp -129.44 146.14 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.178 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.5 t -75.25 54.0 0.68 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.154 0.502 . . . . 0.0 111.288 -179.139 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 35.2 t80 -149.73 114.64 5.37 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.149 179.22 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 59.5 m -95.93 145.7 25.19 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.263 -179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -69.36 -38.56 78.13 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 178.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.605 ' HA ' HD13 ' A' ' 16' ' ' ILE . 13.3 t -84.33 -0.79 53.86 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 12.0 pt-20 -71.12 -30.98 67.17 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 119.422 -0.911 . . . . 0.0 111.374 -179.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG13 HD12 ' A' ' 16' ' ' ILE . 13.0 p -62.46 -27.3 42.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.038 0.447 . . . . 0.0 110.478 179.113 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.605 HD13 ' HA ' ' A' ' 13' ' ' THR . 4.0 mp -74.25 -33.98 36.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.168 0 CA-C-O 121.355 0.598 . . . . 0.0 110.386 179.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.13 -22.66 0.18 Allowed Glycine 0 C--N 1.319 -0.385 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.406 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.493 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.0 m -64.42 170.43 3.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.173 0.511 . . . . 0.0 111.653 -179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 25.8 m -150.12 140.28 22.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.059 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 32.4 t -69.59 131.71 45.08 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.485 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 19.5 ttpp -149.36 119.73 7.36 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 -179.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.576 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 7.6 p-10 44.88 47.15 9.18 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.502 0.721 . . . . 0.0 112.17 -179.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 30.0 ttmt 78.54 -13.38 0.97 Allowed 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 113.549 0.944 . . . . 0.0 113.549 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.9 p -112.46 136.75 47.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 O-C-N 121.229 -0.919 . . . . 0.0 111.419 179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 29.5 m -83.55 118.99 24.17 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.998 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.8 m-30 -127.48 157.15 40.85 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.47 -179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.633 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.4 tt -133.87 103.79 6.0 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 178.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 44.8 t30 56.62 48.14 17.08 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.487 0.661 . . . . 0.0 109.881 -178.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 39.8 m 72.33 -4.3 2.07 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.662 -179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.6 mt -89.6 133.95 30.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 120.619 0.247 . . . . 0.0 110.341 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.0 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.755 0.312 . . . . 0.0 110.727 179.945 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.617 ' SG ' HD23 ' A' ' 27' ' ' LEU . 64.7 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.012 0.434 . . . . 0.0 110.564 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 72.71 33.42 60.5 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.685 -0.769 . . . . 0.0 111.946 -179.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 17.1 tt0 -137.74 156.84 47.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.187 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 38.7 p -132.91 125.88 30.87 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.155 0.502 . . . . 0.0 111.805 -179.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.467 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -91.26 35.83 0.93 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.714 178.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -64.03 -31.74 73.04 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.016 -0.993 . . . . 0.0 112.082 -179.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.4 ttp -88.08 -56.71 3.21 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.684 0.754 . . . . 0.0 110.15 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.7 pt -126.24 138.32 54.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.753 -1.112 . . . . 0.0 109.259 179.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 22.7 t -75.41 48.03 0.41 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.252 0.549 . . . . 0.0 111.402 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.23 116.18 5.24 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 22.1 m -92.5 148.17 22.31 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.643 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 8.0 p90 -70.94 -32.55 69.48 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.5 t -82.42 -3.94 56.52 Favored 'General case' 0 CA--C 1.532 0.276 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.586 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.622 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 15.2 tt0 -63.65 -41.41 98.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.332 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 29.5 t -61.26 -31.37 50.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.661 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 55.1 mt -70.86 -32.15 47.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.404 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.51 -19.52 0.26 Allowed Glycine 0 C--N 1.318 -0.458 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.682 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.602 ' SG ' ' HB3' ' A' ' 27' ' ' LEU . 98.8 m -69.36 169.44 12.33 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.149 0.499 . . . . 0.0 111.686 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.0 m -150.72 130.65 13.35 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.771 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.9 t -58.75 135.85 57.57 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.109 0.481 . . . . 0.0 110.712 -179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 16.8 ttmm -151.45 116.13 5.15 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.492 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.674 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 19.1 p30 46.87 40.77 9.6 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 123.628 0.771 . . . . 0.0 112.594 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.674 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 87.06 -15.8 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.521 0.729 . . . . 0.0 112.464 178.845 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.538 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 21.5 t -110.79 136.05 48.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 O-C-N 121.504 -0.748 . . . . 0.0 110.875 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 31.3 m -81.96 125.67 31.04 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.18 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.538 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.7 m-85 -131.23 140.88 49.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.289 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.617 HD23 ' SG ' ' A' ' 1' ' ' CYS . 1.8 pp -108.18 102.43 11.57 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 106.881 -1.525 . . . . 0.0 106.881 176.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.4 t30 58.36 44.56 18.2 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.229 -177.12 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 32.6 m 75.41 -1.61 3.0 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.622 -1.172 . . . . 0.0 112.843 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.571 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 69.7 mt -88.99 132.72 33.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 N-CA-C 110.028 -0.36 . . . . 0.0 110.028 179.086 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.402 0 CA-C-O 120.98 0.419 . . . . 0.0 111.746 -179.305 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.659 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 92.5 m . . . . . 0 CA--C 1.519 -0.233 0 CA-C-O 120.449 0.166 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.57 37.83 93.99 Favored Glycine 0 C--O 1.227 -0.29 0 C-N-CA 120.401 -0.904 . . . . 0.0 110.99 -179.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.741 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 3.9 tp10 -142.55 149.47 39.12 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 -179.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.2 p -136.34 131.55 34.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.51 0.672 . . . . 0.0 112.529 -178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.45 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -96.19 37.11 1.26 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.22 -0.9 . . . . 0.0 109.493 178.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.06 -39.14 93.84 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 115.04 -0.982 . . . . 0.0 112.146 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.7 ttp -88.75 -59.31 2.26 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.632 0.729 . . . . 0.0 110.425 -179.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.4 pt -116.01 139.13 44.05 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.688 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.45 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.6 t -76.45 49.86 0.62 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.241 0.543 . . . . 0.0 110.924 -179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -151.64 119.81 6.31 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.167 179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.91 ' HB2' ' HG3' ' A' ' 14' ' ' GLU . 17.0 m -95.56 140.89 29.75 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.246 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -64.0 -36.97 85.71 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.524 0.678 . . . . 0.0 109.292 178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.476 HG21 ' HB3' ' A' ' 1' ' ' CYS . 11.3 t -84.43 0.08 50.88 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.49 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.91 ' HG3' ' HB2' ' A' ' 11' ' ' CYS . 8.3 mt-10 -63.53 -46.39 86.24 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-O 121.164 0.507 . . . . 0.0 111.232 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.7 p -56.2 -26.58 22.14 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-N 115.118 -0.947 . . . . 0.0 111.203 179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 44.7 mm -74.94 -30.36 23.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-O 121.228 0.537 . . . . 0.0 111.084 179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 156.81 -21.41 0.45 Allowed Glycine 0 C--N 1.321 -0.295 0 CA-C-N 115.726 -0.67 . . . . 0.0 112.461 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.4 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.0 m -67.56 169.48 9.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.015 0.436 . . . . 0.0 111.843 -179.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.525 ' HA ' ' HG2' ' A' ' 14' ' ' GLU . 61.3 p -148.57 134.08 18.66 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.385 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 22.6 t -60.82 135.43 57.77 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.7 ttmm -151.8 115.45 4.85 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 120.466 -0.493 . . . . 0.0 110.027 -178.646 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.592 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.0 p-10 43.56 48.87 6.4 Favored 'General case' 0 N--CA 1.468 0.45 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.969 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.592 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 32.0 ttpt 81.42 -19.18 0.44 Allowed 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.292 -0.867 . . . . 0.0 113.298 178.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.514 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 16.7 t -111.22 135.24 51.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 O-C-N 121.55 -0.719 . . . . 0.0 111.249 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.741 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 20.8 m -83.61 124.02 30.38 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.999 0.428 . . . . 0.0 111.174 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.514 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 97.0 m-85 -126.78 149.08 49.84 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.757 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.659 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.7 tt -126.24 105.28 8.72 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 106.829 -1.545 . . . . 0.0 106.829 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 45.9 t30 58.87 44.66 16.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.468 0.652 . . . . 0.0 109.472 -178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.0 m 71.74 -2.73 2.38 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 114.889 -1.051 . . . . 0.0 112.428 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 64.4 mt -89.57 135.47 26.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-O 120.613 0.244 . . . . 0.0 110.432 179.597 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 p . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.738 179.785 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.65 ' HB3' HG21 ' A' ' 13' ' ' THR . 88.9 m . . . . . 0 CA--C 1.519 -0.216 0 CA-C-O 121.138 0.494 . . . . 0.0 110.164 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 67.08 29.55 74.66 Favored Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.564 -0.744 . . . . 0.0 112.622 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.719 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 21.6 tt0 -134.18 138.52 45.21 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.3 p -112.07 126.66 55.41 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 112.467 0.543 . . . . 0.0 112.467 -178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.546 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.1 p -98.05 36.52 1.55 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.442 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -62.79 -38.22 89.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.405 -178.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 14.6 tpt -88.23 -55.5 3.71 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 121.663 0.745 . . . . 0.0 110.331 -179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.1 pt -123.99 136.1 61.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 CA-C-N 114.933 -1.03 . . . . 0.0 110.051 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.546 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -77.43 49.69 0.74 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.175 0.512 . . . . 0.0 110.641 -179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.401 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 32.9 t80 -152.16 106.2 3.14 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.951 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.719 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 91.9 m -96.43 155.2 16.86 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.059 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -69.97 -43.22 71.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.004 0.431 . . . . 0.0 109.875 178.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.699 HG22 ' OE1' ' A' ' 3' ' ' GLU . 12.2 t -75.76 -11.51 60.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.58 0.705 . . . . 0.0 110.878 179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.686 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 30.9 tt0 -70.05 -36.31 74.92 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.139 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -58.58 -33.74 49.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.772 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 39.4 pt -92.84 3.01 8.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -178.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.73 -34.15 0.88 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 118.902 -1.618 . . . . 0.0 114.53 179.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.686 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 73.1 m -65.87 169.2 6.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 117.077 0.439 . . . . 0.0 111.602 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 8.4 p -149.17 135.9 19.58 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.67 -179.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.9 t -68.5 127.5 33.23 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.119 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 22' ' ' ASN . 80.2 tttt -150.88 128.05 11.21 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.742 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 3.5 p-10 45.26 44.42 8.98 Favored 'General case' 0 N--CA 1.471 0.597 0 N-CA-C 112.453 0.538 . . . . 0.0 112.453 -179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.0 OUTLIER 76.4 -10.92 1.23 Allowed 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 178.752 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 36.4 t -116.46 134.97 58.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.564 -0.71 . . . . 0.0 110.767 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 23.2 m -85.6 123.51 31.09 Favored 'General case' 0 C--N 1.314 -0.946 0 O-C-N 121.832 -0.542 . . . . 0.0 110.84 179.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.414 ' HD2' ' HB3' ' A' ' 21' ' ' LYS . 65.2 m-85 -120.45 156.01 32.34 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.099 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.626 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.1 tt -129.77 107.01 9.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 177.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.95 44.44 16.45 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.418 0.628 . . . . 0.0 109.471 -178.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 46.6 m 72.49 -4.83 1.96 Allowed 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 114.898 -1.047 . . . . 0.0 112.415 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.8 mt -88.89 133.81 30.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.0 t . . . . . 0 C--N 1.325 -0.48 0 CA-C-O 121.026 0.441 . . . . 0.0 110.566 -179.69 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 13' ' ' THR . 82.6 m . . . . . 0 CA--C 1.519 -0.225 0 CA-C-O 121.265 0.555 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.35 33.17 72.56 Favored Glycine 0 N--CA 1.452 -0.288 0 CA-C-N 115.257 -0.883 . . . . 0.0 112.359 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.732 ' OE1' ' HB3' ' A' ' 11' ' ' CYS . 24.6 tt0 -139.03 139.26 37.76 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.1 p -111.08 129.75 55.82 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 112.652 0.612 . . . . 0.0 112.652 -178.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.505 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.2 p -102.62 38.66 1.66 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.238 178.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.559 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.01 -39.65 95.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.48 -178.775 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.0 tpt -88.32 -57.07 3.06 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 121.684 0.754 . . . . 0.0 110.402 -179.13 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -119.59 135.62 59.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.904 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.99 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.505 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 28.8 t -77.43 49.04 0.69 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.135 0.493 . . . . 0.0 110.659 -179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.44 ' HA ' ' OE1' ' A' ' 14' ' ' GLU . 30.4 t80 -152.19 110.38 3.71 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.876 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.732 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 74.3 m -96.82 160.15 14.52 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.173 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.3 t80 -72.13 -43.21 65.05 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 178.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.698 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.0 t -75.7 -8.15 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.256 0.55 . . . . 0.0 111.022 179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.638 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 10.7 tt0 -62.42 -49.05 77.0 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.866 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 25.4 m -68.59 -19.49 24.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 120.925 0.393 . . . . 0.0 111.122 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 47.7 mm -76.91 -37.82 27.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.572 0.701 . . . . 0.0 110.048 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.58 45.47 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.06 -0.973 . . . . 0.0 112.348 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 62.2 m -137.4 172.67 12.64 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.72 0.295 . . . . 0.0 110.658 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 22.5 m -148.84 132.56 16.91 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.352 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -63.49 130.57 44.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.707 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.682 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 20.7 tptm -145.74 116.86 7.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.033 0.444 . . . . 0.0 110.737 -179.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.682 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 2.6 p-10 44.02 51.13 7.17 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.386 -179.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 18.5 ttpp 79.85 -11.7 1.14 Allowed 'General case' 0 N--CA 1.472 0.656 0 CA-C-N 115.22 -0.9 . . . . 0.0 113.386 178.351 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 6.5 t -122.95 129.79 74.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 O-C-N 121.3 -0.875 . . . . 0.0 110.813 179.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.5 m -77.66 129.67 35.86 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.067 0.461 . . . . 0.0 111.364 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -128.5 157.43 41.18 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.362 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.612 ' O ' ' HG ' ' A' ' 27' ' ' LEU . 2.4 pt? -131.07 107.9 9.39 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.47 45.33 22.73 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.236 0.541 . . . . 0.0 109.929 -178.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 42.2 m 72.49 4.04 4.87 Favored 'General case' 0 N--CA 1.47 0.529 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.424 -179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.521 ' O ' HD23 ' A' ' 27' ' ' LEU . 68.4 mt -96.25 136.37 27.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 179.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 9.7 m . . . . . 0 C--N 1.324 -0.543 0 CA-C-O 120.874 0.369 . . . . 0.0 110.864 -179.786 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.565 ' HB3' HG21 ' A' ' 13' ' ' THR . 83.4 m . . . . . 0 N--CA 1.455 -0.213 0 CA-C-O 120.881 0.372 . . . . 0.0 110.446 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.82 41.03 98.97 Favored Glycine 0 C--O 1.228 -0.231 0 CA-C-N 115.714 -0.675 . . . . 0.0 112.869 179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.647 ' OE1' HG22 ' A' ' 13' ' ' THR . 76.4 tt0 -148.4 154.99 40.66 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -132.98 128.78 37.15 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.129 0.49 . . . . 0.0 111.702 -179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.486 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.6 p -92.33 37.56 1.0 Allowed 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.399 178.31 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -58.86 -38.92 79.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.909 -1.042 . . . . 0.0 112.447 -178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 49.4 tpp -89.4 -62.76 1.4 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.604 0.716 . . . . 0.0 110.175 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.8 pt -109.48 133.58 54.26 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.905 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.579 179.138 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.486 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 24.2 t -76.38 48.69 0.55 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 111.289 -179.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -151.01 120.51 6.91 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 38.1 m -93.44 149.13 21.47 Favored 'General case' 0 C--N 1.315 -0.902 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.184 -179.056 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -66.99 -40.07 87.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.647 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.7 t -81.13 -0.06 38.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.99 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 13.2 tt0 -63.95 -43.01 97.12 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.051 0.453 . . . . 0.0 110.328 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.0 p -63.65 -24.48 35.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.825 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.06 -32.03 22.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.288 0.566 . . . . 0.0 110.724 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.34 -27.05 0.37 Allowed Glycine 0 C--N 1.318 -0.47 0 CA-C-N 115.537 -0.756 . . . . 0.0 112.474 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.522 ' HB2' HG23 ' A' ' 13' ' ' THR . 76.5 m -65.57 169.72 5.85 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 0.0 111.517 -179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.401 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 20.3 m -149.16 138.12 21.31 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.427 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.2 t -63.06 132.17 51.03 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.466 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.519 ' HE3' ' OD1' ' A' ' 22' ' ' ASN . 12.3 ttpt -143.09 111.54 6.26 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 110.287 -0.264 . . . . 0.0 110.287 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.63 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 9.3 p30 40.74 52.06 3.12 Favored 'General case' 0 N--CA 1.466 0.34 0 O-C-N 123.957 0.785 . . . . 0.0 112.708 -179.397 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.63 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 76.9 tttt 84.95 -19.35 0.34 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.858 -1.065 . . . . 0.0 113.833 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.6 133.29 61.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 O-C-N 121.213 -0.929 . . . . 0.0 111.791 179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.1 m -78.11 121.3 24.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.298 -179.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -127.48 156.05 42.76 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.504 0.669 . . . . 0.0 111.956 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 46.6 tp -136.08 101.3 4.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 114.593 -1.185 . . . . 0.0 108.394 178.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 55.47 51.07 13.42 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.107 0.479 . . . . 0.0 110.023 -178.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.4 m 72.92 -6.59 1.65 Allowed 'General case' 0 N--CA 1.469 0.493 0 CA-C-N 115.368 -0.833 . . . . 0.0 112.613 -179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -88.63 135.9 24.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 122.321 -0.237 . . . . 0.0 110.423 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.0 t . . . . . 0 C--N 1.327 -0.395 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.421 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 84.0 m . . . . . 0 CA--C 1.52 -0.199 0 CA-C-O 120.763 0.316 . . . . 0.0 110.456 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.75 34.67 90.58 Favored Glycine 0 C--O 1.228 -0.235 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.145 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.474 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 10.8 tp10 -131.5 147.21 52.52 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 35.3 p -125.21 120.56 31.63 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.36 0.6 . . . . 0.0 111.943 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 5.7 p -95.11 36.9 1.18 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.656 178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.7 -40.48 97.26 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.807 -179.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 48.6 tpp -89.58 -61.66 1.65 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 121.582 0.706 . . . . 0.0 110.535 -179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -111.99 137.32 45.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.142 -0.935 . . . . 0.0 110.368 179.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 35.1 t -79.07 53.6 1.46 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.231 0.539 . . . . 0.0 110.744 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -147.5 119.77 8.36 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.391 -0.822 . . . . 0.0 109.252 179.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.607 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 57.6 m -90.23 142.17 27.99 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.323 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -60.58 -40.54 92.06 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.406 0.622 . . . . 0.0 109.376 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 44.4 p -94.01 15.5 16.79 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.607 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.7 tt0 -60.59 -43.02 97.85 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 121.097 0.475 . . . . 0.0 110.531 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 26.9 t -59.09 -29.22 40.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.058 179.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.6 mt -72.62 -31.18 36.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.151 0.5 . . . . 0.0 110.944 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.82 -19.73 0.88 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.542 -0.837 . . . . 0.0 112.762 179.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.448 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 60.9 m -63.45 157.94 22.08 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.146 0.498 . . . . 0.0 111.376 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 44.2 t -142.34 134.74 27.85 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.186 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 27.7 t -59.89 132.44 53.95 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.145 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HB2' ' HE2' ' A' ' 21' ' ' LYS . 1.1 tppt? -149.62 119.2 6.96 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.591 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 4.9 p-10 43.58 48.51 6.41 Favored 'General case' 0 C--O 1.24 0.569 0 C-N-CA 122.896 0.479 . . . . 0.0 112.194 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.0 ttpm? 79.51 -16.79 0.64 Allowed 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.53 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 22.4 t -113.49 135.57 52.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 O-C-N 121.493 -0.755 . . . . 0.0 111.342 -179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.474 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 84.1 m -80.05 121.94 26.14 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 120.863 0.363 . . . . 0.0 111.013 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.53 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.4 m-85 -123.65 150.96 43.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.258 0.551 . . . . 0.0 111.832 -179.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 44.5 tp -132.26 100.01 4.88 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 178.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 56.21 50.72 12.91 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.14 0.495 . . . . 0.0 109.786 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 17.0 m 73.63 -8.52 1.36 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.339 -0.846 . . . . 0.0 112.445 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.23 132.61 32.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 O-C-N 122.294 -0.254 . . . . 0.0 110.634 179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 26.8 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 179.333 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.706 ' HB3' HG21 ' A' ' 13' ' ' THR . 78.4 m . . . . . 0 C--O 1.227 -0.128 0 CA-C-O 120.909 0.385 . . . . 0.0 110.747 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.88 38.26 95.85 Favored Glycine 0 C--N 1.331 0.284 0 CA-C-N 115.801 -0.636 . . . . 0.0 112.755 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.669 ' OE1' HG22 ' A' ' 13' ' ' THR . 41.2 tt0 -150.34 156.22 41.1 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.3 p -135.85 133.75 38.11 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.145 0.498 . . . . 0.0 111.668 -179.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.482 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.07 37.97 1.09 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.683 178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -63.58 -36.44 83.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 114.918 -1.037 . . . . 0.0 112.435 -178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.436 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -88.9 -56.72 3.17 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.402 0.62 . . . . 0.0 110.014 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -121.45 138.71 50.9 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.546 178.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.482 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.6 t -76.26 47.99 0.49 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.096 0.474 . . . . 0.0 111.025 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -151.87 114.97 4.71 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.65 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 8.9 m -96.32 152.38 18.64 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.052 -179.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -70.85 -41.12 71.86 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.706 HG21 ' HB3' ' A' ' 1' ' ' CYS . 15.4 t -77.25 -9.77 59.01 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 121.579 0.704 . . . . 0.0 110.653 179.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.642 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 29.3 tt0 -69.69 -34.27 73.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.018 179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.6 t -60.04 -33.42 53.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.791 179.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 41.4 pt -92.09 0.06 9.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 113.204 0.816 . . . . 0.0 113.204 -178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 151.0 -36.85 0.88 Allowed Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 119.085 -1.531 . . . . 0.0 114.404 179.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.501 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 83.7 m -63.04 169.43 3.37 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 117.11 0.455 . . . . 0.0 111.627 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 17.2 m -147.37 138.38 23.65 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.55 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 39.3 t -67.01 132.2 47.42 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.495 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -150.24 118.52 6.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 -179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.624 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 45.19 47.7 10.05 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 123.503 0.721 . . . . 0.0 112.591 -179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.624 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 28.1 tttm 80.3 -15.83 0.71 Allowed 'General case' 0 N--CA 1.473 0.686 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 178.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 10.2 p -111.11 138.2 40.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 O-C-N 121.347 -0.845 . . . . 0.0 111.587 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 14.9 m -83.63 116.19 22.51 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.179 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.3 m-30 -123.11 157.51 32.73 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.402 0.62 . . . . 0.0 111.874 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.3 tp -135.14 103.09 5.41 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.167 178.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.1 t30 58.17 43.57 20.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.531 0.682 . . . . 0.0 109.315 -178.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 37.9 m 72.92 -0.07 3.5 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 114.75 -1.114 . . . . 0.0 112.249 -179.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mm -89.71 136.11 24.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.4 p . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.69 0.281 . . . . 0.0 110.851 179.789 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.664 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.5 m . . . . . 0 CA--C 1.522 -0.113 0 CA-C-O 120.86 0.362 . . . . 0.0 110.922 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.47 36.08 92.74 Favored Glycine 0 C--O 1.229 -0.2 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.173 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.672 ' OE1' HG22 ' A' ' 13' ' ' THR . 42.5 tt0 -146.57 152.78 39.49 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.4 p -135.75 132.44 36.82 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.134 0.492 . . . . 0.0 111.829 -179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.6 p -91.92 35.5 0.98 Allowed 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.741 178.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.581 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.67 -32.88 74.74 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.223 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.493 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.0 tpt -88.35 -53.77 4.52 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-O 121.685 0.755 . . . . 0.0 110.347 -179.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -130.9 143.26 41.4 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.94 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 31.4 t -76.67 54.28 0.95 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.35 0.595 . . . . 0.0 110.481 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 34.6 t80 -150.39 116.39 5.61 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.544 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.622 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 61.7 m -97.46 140.28 32.13 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.703 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -71.14 -30.6 66.69 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.672 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.3 t -94.71 1.31 55.49 Favored 'General case' 0 CA--C 1.537 0.457 0 N-CA-C 113.14 0.792 . . . . 0.0 113.14 -179.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.628 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 15.2 pt-20 -70.87 -29.27 65.32 Favored 'General case' 0 N--CA 1.466 0.333 0 O-C-N 121.036 -1.04 . . . . 0.0 110.627 179.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 39.5 t -61.16 -31.43 50.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.294 0.569 . . . . 0.0 110.069 178.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 46.2 mm -73.12 -31.43 34.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.256 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.43 -20.42 0.23 Allowed Glycine 0 C--N 1.319 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.395 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 78.1 m -65.4 169.06 6.31 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.017 0.437 . . . . 0.0 111.347 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.1 m -150.47 134.99 17.29 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 28.9 t -67.0 126.61 29.68 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.921 0.391 . . . . 0.0 110.33 179.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -151.97 128.63 10.81 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 -179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.568 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.2 p30 47.47 42.56 14.65 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 123.092 0.557 . . . . 0.0 112.123 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.581 ' HG3' ' HB2' ' A' ' 6' ' ' ALA . 13.1 tttm 77.5 -12.1 1.11 Allowed 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 112.838 0.681 . . . . 0.0 112.838 178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.519 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 23.0 t -113.9 140.56 33.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 O-C-N 121.528 -0.733 . . . . 0.0 111.618 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.7 m -82.77 120.07 25.15 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.299 179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.519 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 86.5 m-85 -124.52 139.51 53.81 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.879 0.371 . . . . 0.0 111.461 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.664 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.3 tt -106.75 99.17 8.76 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 177.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 48.3 t30 59.81 45.62 12.41 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.996 -0.742 . . . . 0.0 108.996 -177.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.6 m 74.7 -1.98 2.94 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 114.581 -1.191 . . . . 0.0 112.644 -179.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.4 mt -89.03 131.18 37.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.5 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 121.051 0.453 . . . . 0.0 111.236 -179.497 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.611 ' SG ' HD22 ' A' ' 27' ' ' LEU . 57.6 m . . . . . 0 CA--C 1.519 -0.229 0 CA-C-O 120.988 0.423 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.91 35.36 79.09 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.642 -0.789 . . . . 0.0 111.881 -179.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.503 ' OE1' HG22 ' A' ' 13' ' ' THR . 15.5 tt0 -144.43 162.06 37.44 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 63.2 p -143.68 133.13 23.42 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-O 121.204 0.526 . . . . 0.0 112.233 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.423 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.5 p -90.26 37.02 0.88 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.47 178.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -61.68 -35.36 77.76 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.857 -1.065 . . . . 0.0 112.279 -178.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -89.17 -60.46 1.95 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.65 0.738 . . . . 0.0 110.263 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.6 pt -116.97 139.28 44.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.008 -0.996 . . . . 0.0 109.599 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.423 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 23.2 t -75.65 47.55 0.41 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.206 0.527 . . . . 0.0 111.315 -179.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.4 t80 -151.51 118.45 5.84 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.583 ' HB2' ' HB2' ' A' ' 14' ' ' GLU . 60.5 m -91.57 148.5 22.23 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.834 -179.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -67.25 -42.01 84.67 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.503 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.8 t -79.9 2.4 23.48 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.388 179.431 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.583 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 2.4 tt0 -64.6 -40.46 95.56 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 121.136 0.493 . . . . 0.0 109.938 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 t -64.62 -28.98 46.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.606 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 45.4 mm -71.1 -33.47 51.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.38 -179.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.97 -20.72 0.36 Allowed Glycine 0 C--N 1.318 -0.471 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.249 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.544 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 88.1 m -70.89 170.43 12.65 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 120.798 0.332 . . . . 0.0 111.333 -179.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 23.1 t -150.52 142.98 24.4 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.034 -0.53 . . . . 0.0 109.694 179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 42.8 t -65.92 132.45 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.401 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 23.1 tttp -149.99 116.65 5.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.607 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.4 p30 45.5 45.6 10.53 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 123.368 0.667 . . . . 0.0 112.363 -179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.607 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 81.42 -16.32 0.64 Allowed 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.176 0.806 . . . . 0.0 113.176 178.622 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 8.6 p -110.27 139.84 31.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 O-C-N 121.456 -0.777 . . . . 0.0 111.593 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 22.3 m -84.27 120.04 25.76 Favored 'General case' 0 C--O 1.241 0.618 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.884 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -131.09 156.18 45.66 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.496 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.611 HD22 ' SG ' ' A' ' 1' ' ' CYS . 2.6 pt? -134.14 111.47 10.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.06 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 43.5 t30 55.16 44.51 27.66 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.444 0.64 . . . . 0.0 109.932 -178.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.1 m 67.48 19.47 9.98 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 114.956 -1.02 . . . . 0.0 111.883 -179.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.448 ' O ' HD23 ' A' ' 27' ' ' LEU . 74.7 mt -108.49 135.2 48.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 178.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 C--N 1.325 -0.474 0 CA-C-O 120.715 0.293 . . . . 0.0 111.12 -179.398 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.482 ' HB3' HG21 ' A' ' 13' ' ' THR . 73.6 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.901 0.381 . . . . 0.0 110.596 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 63.04 37.55 95.14 Favored Glycine 0 C--O 1.227 -0.31 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.446 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' OE1' HG22 ' A' ' 13' ' ' THR . 12.8 tt0 -149.54 162.01 41.0 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.2 p -144.54 133.97 23.22 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.226 0.536 . . . . 0.0 111.903 -179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.4 p -89.99 37.26 0.88 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.434 178.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -63.51 -30.96 72.0 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 114.889 -1.05 . . . . 0.0 112.328 -179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 25.7 ttt -88.5 -57.1 3.04 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.707 0.765 . . . . 0.0 110.271 -179.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.561 HD13 ' H ' ' A' ' 8' ' ' ILE . 0.2 OUTLIER -129.18 146.17 34.65 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.917 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.32 179.41 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 33.0 t -75.63 51.16 0.59 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.436 0.636 . . . . 0.0 111.061 -179.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -150.84 115.94 5.32 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.263 -0.88 . . . . 0.0 108.937 179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.693 ' O ' ' HG2' ' A' ' 14' ' ' GLU . 74.3 m -95.26 148.45 22.4 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.568 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -70.55 -39.25 74.08 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.491 HG22 ' OE1' ' A' ' 3' ' ' GLU . 13.4 t -83.28 -3.77 57.78 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 113.137 0.791 . . . . 0.0 113.137 -178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.693 ' HG2' ' O ' ' A' ' 11' ' ' CYS . 11.3 pt-20 -72.22 -32.15 66.49 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 119.453 -0.899 . . . . 0.0 111.186 -179.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 34.1 m -63.36 -23.16 32.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.098 0.475 . . . . 0.0 110.394 178.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 51.4 mt -80.17 -30.56 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.738 179.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 163.08 -28.94 0.25 Allowed Glycine 0 C--N 1.319 -0.404 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.761 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 74.3 m -62.58 171.22 2.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.162 0.506 . . . . 0.0 111.837 -179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 37.2 m -149.24 135.97 19.56 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.341 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 20.1 t -66.27 129.57 40.26 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.66 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.88 ' HA ' ' HE3' ' A' ' 21' ' ' LYS . 0.2 OUTLIER -151.13 127.31 10.52 Favored 'General case' 0 C--O 1.22 -0.496 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 -179.996 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.521 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.8 p30 46.87 41.91 11.31 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.137 0.575 . . . . 0.0 112.299 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 76.89 -10.93 1.26 Allowed 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.647 178.87 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.585 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 26.4 t -111.03 140.13 31.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 O-C-N 121.664 -0.648 . . . . 0.0 111.018 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 17.6 m -82.27 118.51 23.18 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.895 -0.409 . . . . 0.0 109.895 179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.585 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 98.5 m-85 -119.42 153.46 35.18 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.192 0.52 . . . . 0.0 112.093 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.458 ' HB2' ' SG ' ' A' ' 18' ' ' CYS . 56.4 tp -132.78 99.27 4.56 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.6 t30 57.66 47.45 15.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.407 0.623 . . . . 0.0 109.39 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m 73.79 -6.14 1.87 Allowed 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.486 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.8 mt -88.74 135.57 25.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 O-C-N 122.316 -0.24 . . . . 0.0 110.603 179.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 120.83 0.348 . . . . 0.0 110.53 179.532 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' HG21 ' A' ' 13' ' ' THR . 74.7 m . . . . . 0 N--CA 1.455 -0.205 0 CA-C-O 120.974 0.416 . . . . 0.0 110.153 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 64.36 43.03 97.44 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 115.738 -0.665 . . . . 0.0 113.317 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.641 ' OE1' HG22 ' A' ' 13' ' ' THR . 47.4 tt0 -150.52 149.56 30.11 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.301 -0.629 . . . . 0.0 109.301 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 33.5 p -123.65 126.4 46.52 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.08 0.467 . . . . 0.0 111.734 -179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 2.2 p -91.74 36.1 0.96 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.556 -0.747 . . . . 0.0 109.814 178.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.39 71.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.45 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.495 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 2.9 tpt -88.41 -55.67 3.63 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.536 0.684 . . . . 0.0 110.722 -179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.4 pt -130.23 142.3 44.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.9 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.94 179.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.3 t -76.94 53.12 0.91 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.415 0.626 . . . . 0.0 110.864 -179.672 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -149.79 117.39 6.17 Favored 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.613 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 59.6 m -94.96 148.71 22.03 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.734 -0.667 . . . . 0.0 111.267 -178.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.6 t80 -69.31 -37.54 77.83 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 177.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.641 HG22 ' OE1' ' A' ' 3' ' ' GLU . 11.2 t -83.12 4.81 24.87 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.996 179.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.579 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 6.1 tt0 -64.56 -35.71 81.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.295 0.569 . . . . 0.0 110.261 179.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 12.9 p -57.72 -32.36 42.37 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.397 -179.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.63 HG22 ' O ' ' A' ' 13' ' ' THR . 8.2 tp -78.93 -17.33 13.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.827 0.346 . . . . 0.0 111.529 -179.39 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 143.04 -22.57 2.28 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.118 -1.039 . . . . 0.0 113.219 179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 14' ' ' GLU . 76.8 m -59.53 161.08 6.25 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-O 121.016 0.436 . . . . 0.0 111.193 -179.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 15.5 m -146.91 135.32 21.84 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.603 -179.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 37.0 t -58.08 134.63 56.61 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.292 179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.469 ' NZ ' ' HB2' ' A' ' 21' ' ' LYS . 0.1 OUTLIER -151.53 119.08 6.05 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 179.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.536 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 6.3 p-10 43.43 48.97 6.15 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.049 0.54 . . . . 0.0 112.286 -179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.3 OUTLIER 77.75 -11.67 1.17 Allowed 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 115.315 -0.857 . . . . 0.0 113.084 178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.595 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 19.1 t -115.53 135.34 55.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 O-C-N 121.27 -0.894 . . . . 0.0 111.555 179.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 38.0 m -78.2 121.3 24.18 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.234 179.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.595 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 80.5 m-85 -126.69 153.07 45.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.126 0.488 . . . . 0.0 111.984 -179.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.416 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 2.7 tm? -135.86 105.12 5.98 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.072 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 55.26 50.05 15.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.073 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.3 m 72.0 -7.95 1.21 Allowed 'General case' 0 N--CA 1.469 0.497 0 CA-C-N 115.561 -0.745 . . . . 0.0 112.493 -179.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mm -88.58 133.36 31.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 120.695 0.284 . . . . 0.0 110.582 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t . . . . . 0 C--N 1.324 -0.505 0 CA-C-O 120.833 0.349 . . . . 0.0 110.196 179.486 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.605 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 72.3 m . . . . . 0 CA--C 1.522 -0.129 0 CA-C-O 120.843 0.354 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 66.83 40.0 93.59 Favored Glycine 0 C--O 1.228 -0.276 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.478 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.655 ' OE1' HG22 ' A' ' 13' ' ' THR . 43.1 tt0 -146.61 152.16 38.45 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 41.4 p -130.16 130.86 45.26 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.143 0.497 . . . . 0.0 112.187 -178.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.453 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.7 p -94.0 37.58 1.09 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.309 -0.859 . . . . 0.0 109.654 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -60.5 -36.93 79.52 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.021 -0.991 . . . . 0.0 112.39 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.7 tpt -88.45 -59.95 2.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.604 0.716 . . . . 0.0 110.383 -179.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.7 pt -116.64 135.95 55.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.674 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.453 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -76.24 49.94 0.6 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.429 0.633 . . . . 0.0 111.226 -179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 31.8 t80 -150.92 119.14 6.33 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.671 -0.862 . . . . 0.0 108.671 178.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.623 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 60.0 m -91.62 149.11 21.81 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.894 -178.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 28.4 t80 -68.43 -39.4 81.57 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.655 HG22 ' OE1' ' A' ' 3' ' ' GLU . 9.7 t -83.65 5.31 24.94 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.827 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.619 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 11.6 tt0 -63.92 -44.51 92.7 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.191 0.52 . . . . 0.0 110.448 179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.6 m -63.52 -22.95 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.345 179.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.7 mt -77.73 -32.13 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 121.211 0.529 . . . . 0.0 111.022 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 160.0 -25.29 0.3 Allowed Glycine 0 C--N 1.319 -0.406 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.48 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 14' ' ' GLU . 78.8 m -69.1 167.43 16.08 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.848 0.356 . . . . 0.0 111.133 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.471 ' HA ' ' HG3' ' A' ' 14' ' ' GLU . 23.1 t -150.96 142.6 23.63 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 179.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -62.54 127.01 29.3 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.001 0.429 . . . . 0.0 110.594 -179.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.582 ' HG3' ' OD1' ' A' ' 22' ' ' ASN . 51.8 tptt -139.9 111.02 6.96 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.108 -179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.582 ' OD1' ' HG3' ' A' ' 21' ' ' LYS . 3.2 p-10 44.14 50.03 7.53 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.603 -0.726 . . . . 0.0 112.175 -178.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.4 OUTLIER 79.14 -12.26 1.1 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 115.081 -0.963 . . . . 0.0 113.066 178.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.02 132.44 64.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 O-C-N 121.386 -0.821 . . . . 0.0 110.956 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.2 m -76.78 122.59 24.97 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.971 0.415 . . . . 0.0 111.384 -179.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 16.2 m-85 -125.3 153.62 42.98 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.495 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.605 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.5 tt -135.3 104.14 5.77 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 107.513 -1.292 . . . . 0.0 107.513 178.355 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 56.29 47.13 19.82 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.237 0.542 . . . . 0.0 109.899 -178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 31.6 m 73.2 -5.7 1.89 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.539 179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.2 mm -89.79 134.7 28.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 O-C-N 122.335 -0.228 . . . . 0.0 110.438 179.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 p . . . . . 0 C--N 1.327 -0.41 0 CA-C-O 120.765 0.317 . . . . 0.0 110.631 179.653 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.3 m . . . . . 0 CA--C 1.518 -0.275 0 CA-C-O 120.669 0.271 . . . . 0.0 110.488 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.23 35.55 91.07 Favored Glycine 0 C--O 1.228 -0.27 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.553 ' HB3' ' HB2' ' A' ' 25' ' ' CYS . 5.2 tp10 -132.61 145.33 51.01 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 27.4 p -128.07 121.53 29.89 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.364 0.602 . . . . 0.0 111.674 -179.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 6.1 p -98.34 38.46 1.33 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.583 178.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.597 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -64.61 -38.8 92.24 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.167 -0.924 . . . . 0.0 112.382 -178.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.479 ' SD ' HG23 ' A' ' 8' ' ' ILE . 0.1 OUTLIER -89.0 -57.13 3.01 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 121.416 0.627 . . . . 0.0 110.105 -179.473 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 HG23 ' SD ' ' A' ' 7' ' ' MET . 20.4 pt -118.83 139.28 46.74 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.824 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.517 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 4.3 t -78.21 54.3 1.35 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.442 0.639 . . . . 0.0 109.979 179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.68 119.89 11.49 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.14 -0.936 . . . . 0.0 109.064 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 13.5 m -96.13 136.63 36.33 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.201 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -62.85 -32.59 73.85 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.147 0.498 . . . . 0.0 110.022 178.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.644 ' O ' HG22 ' A' ' 16' ' ' ILE . 58.9 p -105.43 15.77 26.63 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -178.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.653 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 11.8 pt-20 -65.45 -28.08 68.97 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.16 0.891 . . . . 0.0 110.783 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.4 m -57.35 -26.86 27.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.439 179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.644 HG22 ' O ' ' A' ' 13' ' ' THR . 9.7 tp -85.53 -8.14 11.08 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 120.883 0.373 . . . . 0.0 111.381 -179.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.32 -20.63 3.33 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.188 -1.006 . . . . 0.0 113.073 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.653 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 59.7 m -59.95 156.48 14.48 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.431 0.634 . . . . 0.0 111.408 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 16.0 m -141.96 137.41 31.21 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.103 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 25.7 t -70.28 129.65 39.9 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.113 179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.409 ' HB2' ' HE3' ' A' ' 21' ' ' LYS . 37.1 ttmt -150.86 120.9 7.17 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.664 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 20.3 p30 45.2 47.2 10.08 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.434 0.694 . . . . 0.0 112.475 -179.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.664 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 2.2 ttpp 82.58 -17.84 0.5 Allowed 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 16.6 m -113.22 135.97 51.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 121.352 -0.843 . . . . 0.0 112.343 179.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.553 ' HB2' ' HB3' ' A' ' 3' ' ' GLU . 83.7 m -88.9 118.97 29.0 Favored 'General case' 0 C--O 1.239 0.518 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.561 179.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -125.34 156.56 38.51 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.476 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.653 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 4.3 tt -131.89 108.17 9.22 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 179.024 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.02 44.88 22.03 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.254 0.549 . . . . 0.0 109.915 -179.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.7 m 72.96 -4.62 2.11 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.33 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 63.6 mt -89.58 133.41 31.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.3 t . . . . . 0 C--N 1.327 -0.413 0 CA-C-O 120.948 0.404 . . . . 0.0 110.393 -179.917 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 94.9 m . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.481 0.181 . . . . 0.0 110.769 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.3 35.33 87.98 Favored Glycine 0 C--N 1.332 0.331 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.754 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.5 tp10 -136.61 144.53 44.15 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.442 -0.948 . . . . 0.0 108.442 -178.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.1 p -131.85 128.71 39.25 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.531 0.681 . . . . 0.0 112.694 -178.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.458 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.0 p -92.37 36.04 1.0 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.277 177.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -62.17 -33.93 75.45 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.05 -0.977 . . . . 0.0 112.537 -178.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 50.1 ttp -88.41 -56.04 3.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-O 121.71 0.767 . . . . 0.0 110.336 -179.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.8 pt -127.31 142.47 43.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.404 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.458 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 26.8 t -74.89 46.79 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.113 0.482 . . . . 0.0 111.387 -179.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 29.3 t80 -152.75 113.83 4.18 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.201 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.754 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 74.0 m -93.64 157.85 15.98 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.352 -179.33 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 t80 -69.69 -42.43 74.11 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 9.0 t -82.4 5.42 20.49 Favored 'General case' 0 CA--C 1.535 0.388 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.228 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.585 ' HB2' ' HB2' ' A' ' 11' ' ' CYS . 19.6 tt0 -67.35 -46.71 72.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.033 0.444 . . . . 0.0 110.502 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.2 m -62.28 -21.51 26.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.293 179.334 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 59.1 mt -76.01 -30.29 20.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.759 -180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 157.0 -24.66 0.48 Allowed Glycine 0 C--N 1.319 -0.375 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.694 179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 63.9 m -65.89 160.4 23.43 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.975 0.417 . . . . 0.0 111.217 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 5.7 p -139.09 137.68 36.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.517 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 40.3 t -67.98 125.35 26.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.3 tptp -151.03 124.98 9.21 Favored 'General case' 0 C--O 1.217 -0.633 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.575 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 22.1 p30 49.65 41.42 21.72 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 122.917 0.487 . . . . 0.0 112.168 -179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.575 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 49.4 tttt 78.89 -14.08 0.9 Allowed 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 112.709 0.633 . . . . 0.0 112.709 178.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 41.7 t -115.26 136.23 52.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 O-C-N 121.606 -0.684 . . . . 0.0 111.045 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 m -85.17 128.21 34.58 Favored 'General case' 0 C--N 1.321 -0.644 0 O-C-N 121.647 -0.658 . . . . 0.0 111.017 179.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -121.35 150.45 41.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.243 -179.406 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 56.2 tp -121.03 100.05 6.85 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 47.5 t30 58.24 48.46 12.65 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.327 0.584 . . . . 0.0 109.427 -178.126 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.1 m 73.96 -5.59 2.01 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.94 -1.027 . . . . 0.0 112.468 -179.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.8 mm -88.84 130.94 37.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 O-C-N 122.163 -0.336 . . . . 0.0 110.678 179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.8 m . . . . . 0 C--N 1.325 -0.469 0 CA-C-O 120.875 0.369 . . . . 0.0 110.475 179.69 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.662 ' SG ' HD23 ' A' ' 27' ' ' LEU . 91.4 m . . . . . 0 CA--C 1.522 -0.12 0 CA-C-O 120.506 0.194 . . . . 0.0 110.752 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.09 42.44 99.79 Favored Glycine 0 C--O 1.227 -0.339 0 C-N-CA 120.572 -0.823 . . . . 0.0 111.083 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.903 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 3.3 tp10 -148.65 148.28 29.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 40.8 p -133.72 127.2 32.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.418 0.628 . . . . 0.0 111.424 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.413 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 2.1 p -94.61 38.29 1.11 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.485 178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' HB2' ' HG3' ' A' ' 23' ' ' LYS . . . -60.93 -43.87 98.01 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 114.933 -1.03 . . . . 0.0 112.406 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 15.3 tpt -89.15 -59.6 2.18 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.65 0.738 . . . . 0.0 110.594 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.3 pt -111.83 138.43 40.6 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.34 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 32.2 t -78.57 52.82 1.22 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.265 0.555 . . . . 0.0 110.236 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . 0.404 ' HA ' ' OE2' ' A' ' 14' ' ' GLU . 35.6 t80 -151.11 116.48 5.37 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.939 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.903 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 3.5 m -96.45 136.32 37.11 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.892 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -68.11 -21.63 64.94 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.332 178.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.418 HG21 ' HB3' ' A' ' 1' ' ' CYS . 6.4 t -99.24 -7.11 26.92 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -179.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.954 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 14.5 pt-20 -70.81 -32.36 69.42 Favored 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 119.457 -0.897 . . . . 0.0 111.183 -179.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 28.8 m -64.69 -23.58 33.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-O 120.832 0.349 . . . . 0.0 110.771 178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . . . . . . . . . 58.0 mt -79.05 -35.17 17.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.461 0.648 . . . . 0.0 110.334 179.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 155.76 45.27 0.02 OUTLIER Glycine 0 C--N 1.318 -0.454 0 CA-C-N 115.164 -0.926 . . . . 0.0 112.283 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.954 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 80.5 m -133.07 175.81 9.05 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.3 m -150.09 133.87 16.81 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.539 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.9 t -69.33 132.68 46.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.414 . . . . 0.0 109.9 179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -151.23 122.25 7.66 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 110.38 -0.23 . . . . 0.0 110.38 -179.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.614 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 5.7 p-10 42.87 49.95 5.16 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.23 0.612 . . . . 0.0 112.401 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.614 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 73.9 tttt 80.28 -18.01 0.53 Allowed 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 178.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 11.8 p -114.86 136.28 52.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 O-C-N 121.343 -0.848 . . . . 0.0 112.009 -179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.626 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 33.9 m -88.34 123.17 32.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.963 -179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -128.8 158.25 39.19 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.915 -179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.662 HD23 ' SG ' ' A' ' 1' ' ' CYS . 2.1 pp -130.34 109.85 11.06 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 107.836 -1.172 . . . . 0.0 107.836 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 52.47 46.31 26.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.241 0.543 . . . . 0.0 110.263 -178.34 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.3 m 68.6 18.56 8.82 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.387 -179.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.49 ' HB ' ' HG ' ' A' ' 27' ' ' LEU . 73.3 mt -111.3 133.93 55.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 178.804 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 C--N 1.326 -0.45 0 CA-C-O 120.825 0.345 . . . . 0.0 111.361 -179.272 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.423 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 79.6 m . . . . . 0 CA--C 1.52 -0.21 0 CA-C-O 120.462 0.172 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 59.63 38.47 93.8 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.569 -0.824 . . . . 0.0 111.053 -179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.679 ' HG3' ' SG ' ' A' ' 25' ' ' CYS . 4.1 tp10 -142.74 150.76 40.5 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -178.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.4 p -136.4 129.54 31.38 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 121.362 0.601 . . . . 0.0 112.107 -179.175 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.0 p -94.0 41.57 1.09 Allowed 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.57 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -56.88 -42.27 79.53 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 113.93 -1.487 . . . . 0.0 113.05 -178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.447 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.5 tpt -89.32 -61.61 1.66 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-O 121.33 0.586 . . . . 0.0 110.832 -179.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.9 pt -119.48 149.67 22.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.473 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.3 t -76.79 54.49 0.99 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.292 0.568 . . . . 0.0 110.621 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -144.41 113.0 6.62 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.326 -0.852 . . . . 0.0 109.569 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.661 ' HB2' ' HB3' ' A' ' 14' ' ' GLU . 22.1 m -95.75 137.6 34.59 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.965 -0.562 . . . . 0.0 109.792 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -64.78 -31.42 72.64 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.435 0.636 . . . . 0.0 109.479 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.621 ' O ' HG22 ' A' ' 16' ' ' ILE . 10.1 t -95.13 6.63 48.54 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -179.129 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.661 ' HB3' ' HB2' ' A' ' 11' ' ' CYS . 22.4 pt-20 -71.36 -25.68 62.48 Favored 'General case' 0 N--CA 1.466 0.355 0 O-C-N 120.855 -1.153 . . . . 0.0 111.064 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 30.6 m -59.23 -28.15 38.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.09 -0.505 . . . . 0.0 112.283 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 13' ' ' THR . 12.8 tt -84.33 -15.09 11.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-O 120.894 0.378 . . . . 0.0 111.502 -179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.06 -25.68 1.43 Allowed Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.425 -0.893 . . . . 0.0 112.876 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 75.9 m -59.26 163.57 3.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.16 0.505 . . . . 0.0 111.59 -179.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 7.9 p -150.62 145.79 26.1 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.701 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -68.93 130.02 41.59 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.116 179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 26' ' ' TYR . 60.5 tttm -148.19 112.73 5.33 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 -179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.615 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 24.2 p30 49.03 44.75 22.86 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 123.63 0.772 . . . . 0.0 112.35 -178.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.615 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 0.7 OUTLIER 80.67 -14.87 0.79 Allowed 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.85 178.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.544 ' HB ' ' CE2' ' A' ' 26' ' ' TYR . 18.2 t -109.98 136.96 44.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 121.876 -0.515 . . . . 0.0 110.368 178.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.679 ' SG ' ' HG3' ' A' ' 3' ' ' GLU . 57.1 m -86.76 124.2 32.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.082 0.468 . . . . 0.0 111.174 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . 0.544 ' CE2' ' HB ' ' A' ' 24' ' ' VAL . 96.8 m-85 -125.95 153.58 44.07 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.471 0.653 . . . . 0.0 112.033 -179.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.423 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 43.7 tp -125.49 99.89 6.23 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 177.385 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 58.11 47.27 14.82 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 38.5 m 73.67 -4.21 2.3 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-N 114.942 -1.026 . . . . 0.0 112.738 -179.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 65.1 mt -88.82 132.85 32.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 O-C-N 122.233 -0.292 . . . . 0.0 110.341 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-O 121.032 0.444 . . . . 0.0 110.27 179.818 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.68 ' SG ' ' HB2' ' A' ' 27' ' ' LEU . 87.0 m . . . . . 0 CA--C 1.519 -0.234 0 CA-C-O 120.536 0.208 . . . . 0.0 110.777 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 61.44 33.84 86.14 Favored Glycine 0 C--N 1.331 0.301 0 N-CA-C 110.246 -1.141 . . . . 0.0 110.246 -178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.64 ' HG2' ' HB3' ' A' ' 11' ' ' CYS . 2.5 tp10 -136.57 145.88 45.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.146 -1.027 . . . . 0.0 108.403 -178.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 37.0 p -135.09 130.18 35.13 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.625 0.726 . . . . 0.0 112.7 -178.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.452 ' HB2' ' HA ' ' A' ' 9' ' ' SER . 1.8 p -91.36 38.08 0.96 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.87 -1.059 . . . . 0.0 108.705 177.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.508 ' HA ' ' HG3' ' A' ' 23' ' ' LYS . . . -60.38 -36.45 78.11 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 114.363 -1.29 . . . . 0.0 112.799 -178.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.464 ' CE ' ' HA ' ' A' ' 7' ' ' MET . 3.3 tpt -88.76 -57.89 2.75 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.717 0.77 . . . . 0.0 110.389 -179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 pt -124.82 145.06 32.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.57 179.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.452 ' HA ' ' HB2' ' A' ' 5' ' ' CYS . 29.6 t -75.25 48.71 0.43 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.117 0.484 . . . . 0.0 111.088 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -152.09 111.95 4.01 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.844 179.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.64 ' HB3' ' HG2' ' A' ' 3' ' ' GLU . 77.6 m -95.12 148.46 22.34 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.508 179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 2.5 p90 -70.93 -24.11 62.38 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.025 0.44 . . . . 0.0 110.894 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.498 HG22 ' HG2' ' A' ' 3' ' ' GLU . 9.5 t -100.81 3.64 42.21 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -179.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.728 ' HA ' ' HB2' ' A' ' 18' ' ' CYS . 10.9 pt-20 -78.54 -34.25 47.27 Favored 'General case' 0 C--N 1.322 -0.596 0 O-C-N 121.34 -0.85 . . . . 0.0 111.021 -179.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.409 HG13 HG23 ' A' ' 16' ' ' ILE . 12.0 p -57.87 -27.88 31.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.844 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ILE . . . . . 0.409 HG23 HG13 ' A' ' 15' ' ' VAL . 39.6 pt -95.06 4.78 8.46 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 N-CA-C 113.199 0.815 . . . . 0.0 113.199 -179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.98 -38.38 0.98 Allowed Glycine 0 C--N 1.332 0.353 0 C-N-CA 119.218 -1.468 . . . . 0.0 114.126 179.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.728 ' HB2' ' HA ' ' A' ' 14' ' ' GLU . 77.0 m -65.01 166.93 8.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.027 0.441 . . . . 0.0 111.448 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 11.9 p -147.85 135.96 21.29 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.531 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 36.1 t -71.43 124.35 24.42 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.97 0.414 . . . . 0.0 110.833 -179.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 15.4 tptp -150.72 126.78 10.49 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASN . . . . . 0.574 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 21.5 p30 50.76 37.35 16.63 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 123.052 0.541 . . . . 0.0 112.065 -178.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HB3' ' O ' ' A' ' 22' ' ' ASN . 26.0 ttmt 79.13 -11.28 1.23 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 123.358 0.663 . . . . 0.0 112.624 178.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 39.8 t -114.14 136.63 50.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 O-C-N 121.612 -0.68 . . . . 0.0 110.581 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 m -88.54 128.06 35.55 Favored 'General case' 0 C--N 1.321 -0.643 0 O-C-N 121.561 -0.712 . . . . 0.0 111.703 179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TYR . . . . . . . . . . . . . 50.2 m-85 -122.45 149.82 43.34 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.559 -179.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.68 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 5.0 tt -121.62 104.63 9.77 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 46.4 t30 58.45 46.89 14.45 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.35 0.595 . . . . 0.0 109.488 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 19.2 m 73.31 -6.73 1.67 Allowed 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 114.943 -1.026 . . . . 0.0 112.616 -179.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.02 132.95 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 O-C-N 122.198 -0.314 . . . . 0.0 110.515 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.1 m . . . . . 0 C--N 1.327 -0.375 0 CA-C-O 120.936 0.398 . . . . 0.0 110.786 179.883 . . . . . . . . 0 0 . 1 stop_ save_